Shares of Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) traded up 12.5% during mid-day trading on Wednesday . The company traded as high as $0.27 and last traded at $0.27. 2,000 shares were traded during trading, a decline of 83% from the average session volume of 11,615 shares. The stock had previously closed at $0.24.
Guided Therapeutics Trading Up 12.5%
The business’s fifty day simple moving average is $0.25 and its 200-day simple moving average is $0.19. The firm has a market cap of $22.57 million, a P/E ratio of -5.40 and a beta of 0.40.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last issued its earnings results on Thursday, August 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.12 million for the quarter.
Guided Therapeutics Company Profile
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Further Reading
- Five stocks we like better than Guided Therapeutics
- What Does a Stock Split Mean?
- Datavault AI: The New AI Contender Backed by Big Funding
- Transportation Stocks Investing
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- What does consumer price index measure?
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
